Our team of distinguished journalists will deliver extensive subscriber-only content to you each week, including:
- Comprehensive analyses and insights on the pharmaceutical and biotech industries
- Exclusive one-on-one interviews with industry pioneers
- Inside intelligence from Capitol Hill
- A first look at cutting edge laboratories and early stage research
- Data visualizations on key industry trends
With a STAT Plus subscription, you also receive two subscriber-only, daily newsletters. Additionally, you benefit from early-bird access to reports, exclusive invitations to events, and opportunities to engage with our journalists and experts in the field.